US20030036092A1
(en)
*
|
1991-11-15 |
2003-02-20 |
Board Of Regents, The University Of Texas System |
Directed evolution of enzymes and antibodies
|
US5866344A
(en)
*
|
1991-11-15 |
1999-02-02 |
Board Of Regents, The University Of Texas System |
Antibody selection methods using cell surface expressed libraries
|
US6696251B1
(en)
*
|
1996-05-31 |
2004-02-24 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6759243B2
(en)
*
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
EP2287185A3
(en)
|
1999-12-06 |
2012-10-10 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
EP1242457B1
(en)
|
1999-12-28 |
2004-08-11 |
Esbatech AG |
Intrabodies with defined framework that is stable in a reducing environment and applications thereof
|
AU2001266557A1
(en)
*
|
2000-04-12 |
2001-10-23 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
CA2407910C
(en)
*
|
2000-06-16 |
2013-03-12 |
Steven M. Ruben |
Antibodies that immunospecifically bind to blys
|
EP2042518A3
(en)
|
2000-06-29 |
2009-04-08 |
Abbott Laboratories |
Dual specificity antibodies and methods of making and using
|
US7138496B2
(en)
*
|
2002-02-08 |
2006-11-21 |
Genetastix Corporation |
Human monoclonal antibodies against human CXCR4
|
AU2002211201B2
(en)
*
|
2000-11-02 |
2007-05-31 |
The National University Of Singapore |
aopB Gene, protein, homologs, fragments and variants thereof, and their use for cell surface display
|
JP2002320485A
(ja)
*
|
2000-11-21 |
2002-11-05 |
National Institute Of Advanced Industrial & Technology |
融合遺伝子発現ベクター及び固定化酵素の製造方法
|
US20020165149A1
(en)
*
|
2000-12-08 |
2002-11-07 |
Kranz David M. |
Mutated class II major histocompatibility proteins
|
WO2002046399A2
(en)
*
|
2000-12-08 |
2002-06-13 |
The Board Of Trustees Of The University Of Illinois |
Mutated class i major histocompatibility proteins and complexes
|
AU2002249854B2
(en)
|
2000-12-18 |
2007-09-20 |
Dyax Corp. |
Focused libraries of genetic packages
|
WO2002077207A1
(en)
*
|
2001-03-23 |
2002-10-03 |
Surromed, Inc. |
Cell-based assays for the simultaneous and discrete analysis of multiple analytes
|
PT1298207E
(pt)
*
|
2001-10-01 |
2010-11-08 |
Deutsches Krebsforsch |
Processo para a produção de bibliotecas de proteínas e para a selecção de proteínas a partir da mesma
|
AU2013203954B2
(en)
*
|
2001-10-01 |
2016-06-30 |
Takeda Pharmaceutical Company Limited |
Multi-chain eukaryotic display vectors and uses thereof
|
EP1438400B1
(en)
|
2001-10-01 |
2009-06-17 |
Dyax Corp. |
Multi-chain eukaryotic display vectors and uses thereof
|
AU2002354047B2
(en)
*
|
2001-11-05 |
2007-11-22 |
Board Of Regents, The University Of Texas System |
Recombinant antibodies for the detection and neutralization of anthrax toxin
|
EP2261250B1
(en)
|
2001-12-21 |
2015-07-01 |
Human Genome Sciences, Inc. |
GCSF-Albumin fusion proteins
|
WO2003059934A2
(en)
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US6712102B2
(en)
*
|
2002-05-07 |
2004-03-30 |
Russell Shane Zerangue, Sr. |
Method and system for preventing vehicle misfuelling
|
AU2003240005B2
(en)
*
|
2002-06-14 |
2010-08-12 |
Takeda Pharmaceutical Company Limited |
Recombination of nucleic acid library members
|
JP4748984B2
(ja)
*
|
2002-06-16 |
2011-08-17 |
ダイアックス、コープ |
核酸ライブラリーメンバーの組換え
|
ATE497774T1
(de)
|
2002-07-15 |
2011-02-15 |
Univ Texas |
Screening kombinatorischer proteinbibliotheken mittels periplasmatischer expression
|
JP4836451B2
(ja)
|
2002-07-18 |
2011-12-14 |
メルス ベー ヴェー |
抗体混合物の組換え生産
|
USRE47770E1
(en)
|
2002-07-18 |
2019-12-17 |
Merus N.V. |
Recombinant production of mixtures of antibodies
|
US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
US8044180B2
(en)
*
|
2002-08-14 |
2011-10-25 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8187593B2
(en)
*
|
2002-08-14 |
2012-05-29 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8968730B2
(en)
|
2002-08-14 |
2015-03-03 |
Macrogenics Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8946387B2
(en)
*
|
2002-08-14 |
2015-02-03 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8530627B2
(en)
*
|
2002-08-14 |
2013-09-10 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8193318B2
(en)
*
|
2002-08-14 |
2012-06-05 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
NZ539226A
(en)
|
2002-11-09 |
2008-09-26 |
Medigene Ltd |
T cell receptor display
|
US7960512B2
(en)
|
2003-01-09 |
2011-06-14 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
US7355008B2
(en)
|
2003-01-09 |
2008-04-08 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
WO2004094613A2
(en)
*
|
2003-04-22 |
2004-11-04 |
Ibc Pharmaceuticals |
Polyvalent protein complex
|
WO2004102201A1
(en)
*
|
2003-05-07 |
2004-11-25 |
Novasite Pharmaceuticals, Inc. |
Gain of function sorting for drug discovery and development
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
WO2004106375A1
(en)
|
2003-05-30 |
2004-12-09 |
Merus Biopharmaceuticals B.V. I.O. |
Fab library for the preparation of anti vegf and anti rabies virus fabs
|
ATE447611T1
(de)
|
2003-08-18 |
2009-11-15 |
Univ California |
Polypeptid-display-bibliotheken und verfahren zur herstellung und verwendung davon
|
JP5236189B2
(ja)
|
2003-12-05 |
2013-07-17 |
チルドレンズ ホスピタル メディカル センター |
オリゴ糖組成物および感染症の治療における該組成物の使用
|
AU2005205412B2
(en)
|
2004-01-20 |
2011-08-11 |
Merus N.V. |
Mixtures of binding proteins
|
JP4782700B2
(ja)
|
2004-01-20 |
2011-09-28 |
カロバイオス ファーマシューティカルズ インコーポレイティッド |
最低限必須な結合決定基を用いた抗体特異性の移入
|
US7442773B2
(en)
*
|
2004-01-23 |
2008-10-28 |
The Board Of Trustees Of The University Of Illinois |
Universal peptide-binding scaffolds and protein chips
|
KR20070007793A
(ko)
*
|
2004-02-05 |
2007-01-16 |
메사추세츠 인스티튜트 오브 테크놀로지 |
세포 디스플레이 라이브러리
|
WO2005075647A1
(en)
*
|
2004-02-06 |
2005-08-18 |
Nymox Corporation |
Humanized antibody
|
HUE027902T2
(en)
*
|
2004-02-09 |
2016-11-28 |
Human Genome Sciences Inc Corp Service Company |
Albumin fusion proteins
|
WO2005110474A2
(en)
*
|
2004-05-10 |
2005-11-24 |
Macrogenics, Inc. |
HUMANIZED FcϜRIIB SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
|
US7632497B2
(en)
*
|
2004-11-10 |
2009-12-15 |
Macrogenics, Inc. |
Engineering Fc Antibody regions to confer effector function
|
EP1674479A1
(en)
*
|
2004-12-22 |
2006-06-28 |
Memorial Sloan-Kettering Cancer Center |
Modulation of Fc Gamma receptors for optimizing immunotherapy
|
US11254748B2
(en)
|
2005-04-15 |
2022-02-22 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
ES2707152T3
(es)
|
2005-04-15 |
2019-04-02 |
Macrogenics Inc |
Diacuerpos covalentes y usos de los mismos
|
US9889197B2
(en)
|
2005-04-15 |
2018-02-13 |
Macrogenics, Inc. |
Covalently-associated diabody complexes that possess charged coil domains and that are capable of enhanced binding to serum albumin
|
US9284375B2
(en)
*
|
2005-04-15 |
2016-03-15 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
US9963510B2
(en)
*
|
2005-04-15 |
2018-05-08 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
CA2610931A1
(en)
*
|
2005-06-17 |
2006-12-28 |
Biorexis Pharmaceutical Corporation |
Anchored transferrin fusion protein libraries
|
JP5577006B2
(ja)
*
|
2005-07-01 |
2014-08-20 |
味の素株式会社 |
迅速スクリーニング方法及び該方法で得られた微生物
|
SI1919503T1
(sl)
*
|
2005-08-10 |
2015-02-27 |
Macrogenics, Inc. |
Identifikacija in inĺ˝eniring protiteles z variantnimi fc regijami in postopki za njih uporabo
|
EP1919931A4
(en)
|
2005-08-31 |
2010-01-20 |
Univ California |
CELLULAR LIBRARIES OF PEPTIDE SEQUENCES (CLIPS) AND METHODS OF USE THEREOF
|
JP2009510002A
(ja)
|
2005-09-30 |
2009-03-12 |
アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
反発誘導分子(rgm)タンパク質ファミリーのタンパク質の結合ドメイン、及びその機能的断片、及びそれらの使用
|
RU2442793C2
(ru)
|
2005-11-30 |
2012-02-20 |
Эбботт Лэборетриз |
АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
|
SG2014013437A
(en)
|
2005-11-30 |
2014-07-30 |
Abbott Lab |
Monoclonal antibodies and uses thereof
|
AU2007211829C9
(en)
|
2006-02-01 |
2013-07-11 |
Cephalon Australia Pty Ltd |
Domain antibody construct
|
EP1816201A1
(en)
*
|
2006-02-06 |
2007-08-08 |
CSL Behring GmbH |
Modified coagulation factor VIIa with extended half-life
|
AU2007226752A1
(en)
*
|
2006-03-10 |
2007-09-20 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant heavy chains and methods of using same
|
CA2647671A1
(en)
*
|
2006-03-31 |
2007-11-01 |
Massachusetts Institute Of Technology |
Treatment of tumors expressing mutant egf receptors
|
US8022188B2
(en)
*
|
2006-04-24 |
2011-09-20 |
Abbott Laboratories |
Immunosuppressant binding antibodies and methods of obtaining and using same
|
JP2009535063A
(ja)
|
2006-05-04 |
2009-10-01 |
アブマクシス・インコーポレイテツド |
異種間及び複数種提示系
|
EP1918302A3
(en)
*
|
2006-05-18 |
2009-11-18 |
AvantGen, Inc. |
Methods for the identification and the isolation of epitope specific antibodies
|
CA2660592C
(en)
|
2006-05-26 |
2016-07-12 |
Macrogenics, Inc. |
Humanized fc.gamma.riib-specific antibodies and methods of use thereof
|
EP2032159B1
(en)
*
|
2006-06-26 |
2015-01-07 |
MacroGenics, Inc. |
Combination of fcgammariib antibodies and cd20-specific antibodies and methods of use thereof
|
LT2029173T
(lt)
|
2006-06-26 |
2016-11-10 |
Macrogenics, Inc. |
Fc riib specifiniai antikūnai ir jų panaudojimo būdai
|
US7795411B2
(en)
*
|
2006-10-05 |
2010-09-14 |
Fred Hutchinson Cancer Research Center |
Vectors for expressing in vivo biotinylated recombinant proteins
|
US20080112961A1
(en)
*
|
2006-10-09 |
2008-05-15 |
Macrogenics, Inc. |
Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
|
US8183030B2
(en)
*
|
2006-10-13 |
2012-05-22 |
Archer Daniels Midland Company |
Use of cell surface displays in yeast cell catalyst supports
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
US8652466B2
(en)
|
2006-12-08 |
2014-02-18 |
Macrogenics, Inc. |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
|
EP2114999A2
(en)
|
2006-12-12 |
2009-11-11 |
Biorexis Pharmaceutical Corporation |
Transferrin fusion protein libraries
|
WO2008082651A2
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Dual-specific il-1a/ il-1b antibodies
|
US20110076752A1
(en)
*
|
2007-02-09 |
2011-03-31 |
Medimmune, Llc |
Antibody library display by yeast cell plasma membrane
|
US20100311767A1
(en)
|
2007-02-27 |
2010-12-09 |
Abbott Gmbh & Co. Kg |
Method for the treatment of amyloidoses
|
WO2008118476A2
(en)
|
2007-03-26 |
2008-10-02 |
Codon Devices, Inc. |
Cell surface display, screening and production of proteins of interest
|
CN104480140B
(zh)
|
2007-04-03 |
2019-12-31 |
奥克西雷恩英国有限公司 |
分子的糖基化
|
WO2009014726A1
(en)
|
2007-07-26 |
2009-01-29 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
US8680019B2
(en)
|
2007-08-10 |
2014-03-25 |
Protelica, Inc. |
Universal fibronectin Type III binding-domain libraries
|
US20090176654A1
(en)
*
|
2007-08-10 |
2009-07-09 |
Protelix, Inc. |
Universal fibronectin type III binding-domain libraries
|
US8470966B2
(en)
|
2007-08-10 |
2013-06-25 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
DK2190987T3
(da)
|
2007-08-21 |
2013-02-18 |
Morphosys Ag |
Fremgangsmåder til dannelse af disulfidbindinger
|
US8034607B2
(en)
*
|
2007-09-12 |
2011-10-11 |
Wisconsin Alumni Research Foundation |
Methods of enhanced heterologous protein secretion
|
CA3187687A1
(en)
|
2007-09-14 |
2009-03-19 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
US8637435B2
(en)
*
|
2007-11-16 |
2014-01-28 |
Merck Sharp & Dohme Corp. |
Eukaryotic cell display systems
|
US8420081B2
(en)
|
2007-11-30 |
2013-04-16 |
Abbvie, Inc. |
Antibody formulations and methods of making same
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
WO2009117030A2
(en)
*
|
2007-12-19 |
2009-09-24 |
Macrogenics, Inc. |
Improved compositions for the prevention and treatment of smallpox
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
JP5731827B2
(ja)
*
|
2008-03-03 |
2015-06-10 |
グライコフィ, インコーポレイテッド |
下等真核生物中での組換えタンパク質の表面ディスプレイ
|
BRPI0906309A2
(pt)
*
|
2008-04-02 |
2020-05-26 |
Macrogenics, Inc |
Imunoglobulina, anticorpo, uso do anticorpo e composição farmacêutica
|
CN106349390B
(zh)
|
2008-04-02 |
2019-12-10 |
宏观基因有限公司 |
Bcr-复合体-特异性抗体和其使用方法
|
US20110081347A1
(en)
*
|
2008-06-04 |
2011-04-07 |
Macrogenics, Inc. |
Antibodies with Altered Binding to FcRn and Methods of Using Same
|
US8067339B2
(en)
|
2008-07-09 |
2011-11-29 |
Merck Sharp & Dohme Corp. |
Surface display of whole antibodies in eukaryotes
|
JP5985826B2
(ja)
|
2008-12-16 |
2016-09-06 |
ノバルティス アーゲー |
酵母ディスプレイ系
|
WO2010079189A1
(en)
*
|
2009-01-09 |
2010-07-15 |
Morphosys Ag |
Display vectors and methods and uses thereof
|
CN104651428A
(zh)
|
2009-09-29 |
2015-05-27 |
根特大学 |
水解甘露糖-1-磷酸-6-甘露糖连接为磷酸-6-甘露糖
|
CA2777053A1
(en)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Human single-chain t cell receptors
|
CA2776385C
(en)
|
2009-10-07 |
2019-04-09 |
Macrogenics, Inc. |
Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
|
US9139825B2
(en)
|
2009-10-30 |
2015-09-22 |
Novartis Ag |
Universal fibronectin type III bottom-side binding domain libraries
|
WO2011060233A1
(en)
|
2009-11-11 |
2011-05-19 |
The Trustees Of The University Of Pennsylvania |
Anti-tem1 antibodies and uses thereof
|
BR112012011980A2
(pt)
|
2009-11-19 |
2021-09-08 |
Oxyrane Uk Limited |
Métodos de produzir células transformadas de yarrowia lipolytica e proteínas-alvocompreendendo n-glicanos, células transformadas de yarrowia lipolytica e suas culturas, bem como composição compreendendo glicoproteínas
|
MX2012006560A
(es)
|
2009-12-08 |
2012-10-05 |
Abbott Gmbh & Co Kg |
Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal.
|
US20130096281A1
(en)
*
|
2010-01-21 |
2013-04-18 |
Oxyrane Uk Limited |
Methods and compositions for displaying a polypeptide on a yeast cell surface
|
US8802091B2
(en)
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
PH12018501083A1
(en)
|
2010-03-04 |
2019-02-18 |
Macrogenics Inc |
Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
|
MX360403B
(es)
|
2010-04-15 |
2018-10-31 |
Abbvie Inc |
Proteinas de union a amiloide beta.
|
DK2593594T3
(da)
|
2010-07-16 |
2017-12-11 |
Adimab Llc |
Antistofbiblioteker
|
CN103403027A
(zh)
|
2010-07-30 |
2013-11-20 |
诺华有限公司 |
纤连蛋白摇篮分子和其库
|
JP6147665B2
(ja)
|
2010-08-14 |
2017-06-14 |
アッヴィ・インコーポレイテッド |
アミロイドベータ結合タンパク質
|
CN103328646B
(zh)
|
2010-09-29 |
2021-06-18 |
奥克西雷恩英国有限公司 |
能够使甘露糖-1-磷酸-6-甘露糖连接脱帽并使磷酸化的n-聚糖脱甘露糖基化的甘露糖苷酶及促进糖蛋白的哺乳动物细胞摄取的方法
|
US9689015B2
(en)
|
2010-09-29 |
2017-06-27 |
Oxyrane Uk Limited |
De-mannosylation of phosphorylated N-glycans
|
EP2710382B1
(en)
|
2011-05-17 |
2017-10-18 |
Bristol-Myers Squibb Company |
Improved methods for the selection of binding proteins
|
EA201391753A1
(ru)
|
2011-05-21 |
2014-08-29 |
Макродженикс, Инк. |
Домены, связывающиеся с деиммунизованной сывороткой, и их применение для увеличения времени полужизни в сыворотке
|
PL2807192T3
(pl)
|
2012-01-27 |
2019-02-28 |
Abbvie Deutschland |
Kompozycja oraz sposób diagnostyki i leczenia chorób związanych ze zwyrodnieniem neurytów
|
US9249399B2
(en)
|
2012-03-15 |
2016-02-02 |
Oxyrane Uk Limited |
Methods and materials for treatment of pompe's disease
|
PT2838917T
(pt)
|
2012-04-20 |
2019-09-12 |
Merus Nv |
Métodos e meios para a produção de moléculas similares a ig heterodiméricas
|
WO2013162748A1
(en)
|
2012-04-27 |
2013-10-31 |
The Trustees Of The University Of Pennsylvania |
Anti-tumor endothelial marker-1 (tem1) antibody variants and uses thereof
|
DK2831276T3
(da)
|
2012-05-08 |
2016-08-01 |
Adaptive Biotechnologies Corp |
Sammensætninger og fremgangsmåde til at måle og kalibrere amplifikations-bias i multipleks-PCR-reaktioner
|
MX2015000979A
(es)
|
2012-07-27 |
2015-11-23 |
Univ Illinois |
Ingenieria de receptores de celulas t.
|
EP2890836B1
(en)
*
|
2012-08-31 |
2019-07-17 |
The Scripps Research Institute |
Methods related to modulators of eukaryotic cells
|
EP2708556B1
(en)
|
2012-09-12 |
2018-11-07 |
Samsung Electronics Co., Ltd |
Pharmaceutical composition for the use in a combination therapy for prevention or treatment of c-met or angiogenesis factor induced diseases
|
EP2929351B1
(en)
*
|
2012-12-10 |
2019-10-09 |
The University of Queensland |
Cell-free biofragment compositions and related systems, devices, and methods
|
WO2014092960A1
(en)
*
|
2012-12-11 |
2014-06-19 |
Danisco Us Inc. |
Trichoderma reesei host cells expressing a glucoamylase from aspergillus fumigatus and methods of use thereof
|
US9487587B2
(en)
|
2013-03-05 |
2016-11-08 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
|
AU2014244286B2
(en)
|
2013-03-14 |
2018-11-08 |
Duke University |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor
|
EP2991679A4
(en)
*
|
2013-04-29 |
2016-12-07 |
Adimab Llc |
POLYSPECIFIC REAGENTS, PROCESS FOR THEIR PREPARATION AND USE
|
US9708657B2
(en)
|
2013-07-01 |
2017-07-18 |
Adaptive Biotechnologies Corp. |
Method for generating clonotype profiles using sequence tags
|
UA116479C2
(uk)
|
2013-08-09 |
2018-03-26 |
Макродженікс, Інк. |
БІСПЕЦИФІЧНЕ МОНОВАЛЕНТНЕ Fc-ДІАТІЛО, ЯКЕ ОДНОЧАСНО ЗВ'ЯЗУЄ CD32B I CD79b, ТА ЙОГО ЗАСТОСУВАННЯ
|
US11384149B2
(en)
|
2013-08-09 |
2022-07-12 |
Macrogenics, Inc. |
Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof
|
EP2840091A1
(en)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bi-specific diabodies that are capable of binding gpA33 and CD3 and uses thereof
|
EP2839842A1
(en)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof
|
US9717715B2
(en)
|
2013-11-15 |
2017-08-01 |
Samsung Electronics Co., Ltd. |
Method of combination therapy using an anti-C-Met antibody
|
SG10201804335QA
(en)
|
2013-11-22 |
2018-06-28 |
Univ Illinois |
Engineered high-affinity human t cell receptors
|
WO2015100058A1
(en)
|
2013-12-23 |
2015-07-02 |
Research Corporation Technologies, Inc. |
Pichia pastoris surface display system
|
US10066265B2
(en)
|
2014-04-01 |
2018-09-04 |
Adaptive Biotechnologies Corp. |
Determining antigen-specific t-cells
|
US11390921B2
(en)
|
2014-04-01 |
2022-07-19 |
Adaptive Biotechnologies Corporation |
Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
|
US10816554B2
(en)
|
2014-04-04 |
2020-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ligand discovery for T cell receptors
|
EP3172325B1
(en)
|
2014-07-22 |
2023-06-28 |
The University of Notre Dame du Lac |
Molecular constructs and uses thereof
|
US20170260261A1
(en)
|
2014-08-28 |
2017-09-14 |
Bioatla, Llc |
Conditionally Active Chimeric Antigen Receptors for Modified T-Cells
|
US11111288B2
(en)
|
2014-08-28 |
2021-09-07 |
Bioatla, Inc. |
Conditionally active chimeric antigen receptors for modified t-cells
|
AU2015323860B2
(en)
|
2014-09-29 |
2021-05-27 |
Duke University |
Bispecific molecules comprising an HIV-1 envelope targeting arm
|
CA2966201A1
(en)
|
2014-10-29 |
2016-05-06 |
Adaptive Biotechnologies Corp. |
Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
|
WO2016168755A1
(en)
|
2015-04-17 |
2016-10-20 |
Distributed Bio, Inc. |
Method for mass humanization of non-human antibodies
|
US11685773B2
(en)
|
2015-04-30 |
2023-06-27 |
Abcheck S.R.O. |
Method for mass humanization of rabbit antibodies
|
US11136613B2
(en)
|
2015-04-30 |
2021-10-05 |
Board Of Regents, The University Of Texas System |
Antibacterial polypeptide libraries and methods for screening the same
|
GB201520536D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520557D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520570D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520558D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520592D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520595D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201607535D0
(en)
|
2016-04-29 |
2016-06-15 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520545D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520566D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520583D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520567D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520597D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520539D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520563D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520562D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520589D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520565D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520603D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520559D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520550D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520564D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520544D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520546D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201604468D0
(en)
|
2016-03-16 |
2016-04-27 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520542D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520541D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520579D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520548D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520568D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd |
Peptides
|
GB201607534D0
(en)
|
2016-04-29 |
2016-06-15 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520543D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
GB201520575D0
(en)
|
2015-11-23 |
2016-01-06 |
Immunocore Ltd & Adaptimmune Ltd |
Peptides
|
US11384354B2
(en)
|
2015-12-21 |
2022-07-12 |
Zumutor Biologics Inc. |
Method of generating an antibody naïve library, said library and application(s) thereof
|
US11549119B2
(en)
|
2016-04-06 |
2023-01-10 |
Zumutor Biologics, Inc. |
Vectors for cloning and expression of proteins, methods and applications thereof
|
US10961311B2
(en)
|
2016-04-15 |
2021-03-30 |
Macrogenics, Inc. |
B7-H3 binding molecules, antibody drug conjugates thereof and methods of use thereof
|
LT3455261T
(lt)
|
2016-05-13 |
2022-11-10 |
Bioatla, Inc. |
Antikūnai prieš ror2, antikūnų fragmentai, jų imunokonjugatai ir panaudojimas
|
WO2018041740A1
(en)
|
2016-09-01 |
2018-03-08 |
Bayer Pharma Aktiengesellschaft |
Non-covalent display system using fimgt/dsf
|
US10428325B1
(en)
|
2016-09-21 |
2019-10-01 |
Adaptive Biotechnologies Corporation |
Identification of antigen-specific B cell receptors
|
US20210115099A1
(en)
|
2016-11-07 |
2021-04-22 |
Immunocore Limited |
Peptides
|
WO2018104893A1
(en)
|
2016-12-06 |
2018-06-14 |
Glaxosmithkline Intellectual Property Development Limited |
Alpha4-beta7 antibodies with incrased fcrn binding and/or half-life
|
US11254980B1
(en)
|
2017-11-29 |
2022-02-22 |
Adaptive Biotechnologies Corporation |
Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
|
GB201720351D0
(en)
*
|
2017-12-06 |
2018-01-17 |
Iontas Ltd |
Selecting for developability in drug discovery
|
MA51154A
(fr)
|
2017-12-15 |
2020-10-21 |
Aleta Biotherapeutics Inc |
Variants de cd19
|
WO2023051972A1
(en)
|
2021-09-29 |
2023-04-06 |
Miltenyi Biotec B.V. & Co. KG |
Method for the generation and selection of a producer cell
|
ES2955461A1
(es)
*
|
2022-05-24 |
2023-12-01 |
Univ Valencia Politecnica |
Levadura y plasmido para la exposicion de proteinas en superficie
|